
Diego A. Díaz García/X
Aug 6, 2025, 06:42
Diego Díaz-García: A Promising Shift in Neuro-Oncology Strategies
Diego Díaz-García, Medical Oncologist, CEO, Founder at CánCare – Advanced Specialty in Oncology, shared a post on X about a paper by Thomas Kisby et al., published in Nature Reviews Clinical Oncology.
“Glioblastoma can begin to regrow just days after surgery.
Locoregional nanotechnologies offer a way to target the resection margin during this critical window.
A promising shift in neuro-oncology strategies.”
Title: Targeting the glioblastoma resection margin with locoregional nanotechnologies
Authors: Thomas Kisby, Gerben R. Borst, David J. Coope, Kostas Kostarelos
Read The Full Article at Nature Reviews Clinical Oncology.
More posts featuring Diego Díaz García on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 06:42
Aug 6, 2025, 06:26
Aug 6, 2025, 05:59
Aug 6, 2025, 05:45
Aug 6, 2025, 05:24